{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:05:17Z","timestamp":1780524317640,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A controversy effect of perioperative statin use for preventing postoperative atrial fibrillation (POAF) and acute kidney injury (AKI) after cardiac surgery still remains. We thus performed current systematic review and meta-analysis to comprehensively evaluate effects of statin in cardiac surgery. 22 RCTs involving 5243 patients were included. Meta-analysis of 18 randomized controlled trials with 3995 participants suggested that perioperative statin use could decrease the risk of POAF (relative risk [RR] 0.69, 95%CI 0.56 to 0.86, <jats:italic>P<\/jats:italic>\u2009=\u20090.001), with a moderate heterogeneity (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200965.7%, <jats:italic>P<\/jats:italic><jats:sub>\n                  <jats:italic>H<\/jats:italic>\n                <\/jats:sub>\u2009&lt;\u20090.001). And the beneficial effect was found only in patients receiving coronary artery bypass graft (CABG), but not in patients undergoing valve surgery. However, perioperative statin use was not associated with lower risks of AKI (RR 0.98, 95%CI 0.70 to 1.35, <jats:italic>P<\/jats:italic>\u2009=\u20090.884, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200933.9%, <jats:italic>P<\/jats:italic><jats:sub>\n                  <jats:italic>H<\/jats:italic>\n                <\/jats:sub>\u2009=\u20090.157) or myocardial infarction (MI) (RR 0.84, 95%CI 0.58 to 1.23, <jats:italic>P<\/jats:italic>\u2009=\u20090.380, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090%, <jats:italic>P<\/jats:italic><jats:sub>\n                  <jats:italic>H<\/jats:italic>\n                <\/jats:sub>\u2009=\u20090.765), and even an increased trend of AKI was observed in patients with valve surgery. Perioperative statin use could decrease the inflammation response with no impact on clinical outcomes. In conclusion, perioperative statin use is useful in preventing POAF, particularly in patients with CABG, and ameliorate inflammation, while it has no effect on AKI and MI after cardiac surgery.<\/jats:p>","DOI":"10.1038\/s41598-017-10600-x","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T15:50:59Z","timestamp":1503589859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Perioperative statin administration with decreased risk of postoperative atrial fibrillation, but not acute kidney injury or myocardial infarction: A meta-analysis"],"prefix":"10.1038","volume":"7","author":[{"given":"Li","family":"Zhen-Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Xiao-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Qing-Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"10600_CR1","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.athoracsur.2013.05.050","volume":"96","author":"DJ LaPar","year":"2013","unstructured":"LaPar, D. J. et al. A contemporary cost analysis of postoperative morbidity after coronary artery bypass grafting with and without concomitant aortic valve replacement to improve patient quality and cost-effective care. Ann Thorac Surg. \n                           96, 1621\u20131627 (2013).","journal-title":"Ann Thorac Surg."},{"key":"10600_CR2","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.jtcvs.2016.01.050","volume":"151","author":"LK Kim","year":"2016","unstructured":"Kim, L. K. et al. Outcomes in patients undergoing coronary artery bypass graft surgery in the United States based on hospital volume, 2007 to 2011. J Thorac Cardiovasc Surg. \n                           151, 1686\u20131692 (2016).","journal-title":"J Thorac Cardiovasc Surg."},{"key":"10600_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.athoracsur.2009.01.031","volume":"88","author":"A Anselmi","year":"2009","unstructured":"Anselmi, A., Possati, G. & Gaudino, M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann Thorac Surg. \n                           88, 326\u2013333 (2009).","journal-title":"Ann Thorac Surg."},{"key":"10600_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.00240605","volume":"1","author":"MH Rosner","year":"2006","unstructured":"Rosner, M. H. & Okusa, M. D. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. \n                           1, 19\u201332 (2006).","journal-title":"Clin J Am Soc Nephrol."},{"key":"10600_CR5","doi-asserted-by":"publisher","first-page":"9s","DOI":"10.1378\/chest.128.2_suppl.9S","volume":"128","author":"CW Hogue Jr.","year":"2005","unstructured":"Hogue, C. W. Jr., Creswell, L. L., Gutterman, D. D. & Fleisher, L. A. Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. \n                           128, 9s\u201316s (2005).","journal-title":"Chest."},{"key":"10600_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0000000000000409","volume":"42","author":"M Engoren","year":"2014","unstructured":"Engoren, M., Habib, R. H., Arslanian-Engoren, C., Kheterpal, S. & Schwann, T. A. The effect of acute kidney injury and discharge creatinine level on mortality following cardiac surgery*. Crit Care Med. \n                           42, 2069\u20132074 (2014).","journal-title":"Crit Care Med."},{"key":"10600_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/europace\/euv001","volume":"17","author":"G Patti","year":"2015","unstructured":"Patti, G. et al. Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials. Europace. \n                           17, 855\u2013863 (2015).","journal-title":"Europace."},{"key":"10600_CR8","doi-asserted-by":"crossref","unstructured":"Song, Y.B. et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J. 156, 373.e379-316 (2008).","DOI":"10.1016\/j.ahj.2008.04.020"},{"key":"10600_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.athoracsur.2008.01.040","volume":"85","author":"A Kourliouros","year":"2008","unstructured":"Kourliouros, A. et al. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg. \n                           85, 1515\u20131520 (2008).","journal-title":"Ann Thorac Surg."},{"key":"10600_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.amjcard.2012.11.047","volume":"111","author":"JB Layton","year":"2013","unstructured":"Layton, J. B. et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. \n                           111, 823\u2013828 (2013).","journal-title":"Am J Cardiol."},{"key":"10600_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jtcvs.2011.10.015","volume":"143","author":"LD Hillis","year":"2012","unstructured":"Hillis, L. D. et al. 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. \n                           143, 4\u201334 (2012).","journal-title":"J Thorac Cardiovasc Surg."},{"key":"10600_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1440-1797.2011.01546.x","volume":"17","author":"JR Prowle","year":"2012","unstructured":"Prowle, J. R. et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton). \n                           17, 215\u2013224 (2012).","journal-title":"Nephrology (Carlton)."},{"key":"10600_CR13","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00134-016-4358-8","volume":"42","author":"JH Park","year":"2016","unstructured":"Park, J. H., Shim, J. K., Song, J. W., Soh, S. & Kwak, Y. L. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. \n                           42, 1398\u20131407 (2016).","journal-title":"Intensive Care Med."},{"key":"10600_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/jama.2016.0548","volume":"315","author":"FTt Billings","year":"2016","unstructured":"Billings, F. T. et al. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial. Jama. \n                           315, 877\u2013888 (2016).","journal-title":"Jama."},{"key":"10600_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ahj.2007.10.027","volume":"155","author":"SS Virani","year":"2008","unstructured":"Virani, S. S. et al. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J. \n                           155, 541\u2013546 (2008).","journal-title":"Am Heart J."},{"key":"10600_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.hlc.2010.06.664","volume":"19","author":"L Yin","year":"2010","unstructured":"Yin, L., Wang, Z., Wang, Y., Ji, G. & Xu, Z. Effect of statins in preventing postoperative atrial fibrillation following cardiac surgery. Heart Lung Circ. \n                           19, 579\u2013583 (2010).","journal-title":"Heart Lung Circ."},{"key":"10600_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00003643-200805001-00202","volume":"25","author":"E Tamayo.","year":"2009","unstructured":"Tamayo, E. et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. European Journal of Anaesthesiology. \n                           25, 64\u201365 (2009).","journal-title":"European Journal of Anaesthesiology."},{"key":"10600_CR18","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1161\/ATVBAHA.112.252098","volume":"32","author":"MA Almansob","year":"2012","unstructured":"Almansob, M. A. et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. Arterioscler Thromb Vasc Biol. \n                           32, 2304\u20132313 (2012).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10600_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.5152\/akd.2014.5531","volume":"15","author":"U Aydin","year":"2015","unstructured":"Aydin, U. et al. Efficiency of postoperative statin treatment for preventing new-onset postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting: A prospective randomized study. Anatol J Cardiol. \n                           15, 491\u2013495 (2015).","journal-title":"Anatol J Cardiol."},{"key":"10600_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s12015-011-9321-z","volume":"8","author":"C Baran","year":"2012","unstructured":"Baran, C. et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev. \n                           8, 963\u2013971 (2012).","journal-title":"Stem Cell Rev."},{"key":"10600_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-2008-1039107","volume":"57","author":"O Berkan","year":"2009","unstructured":"Berkan, O. et al. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. \n                           57, 91\u201395 (2009).","journal-title":"Thorac Cardiovasc Surg."},{"key":"10600_CR22","first-page":"99","volume":"19","author":"C Caorsi","year":"2008","unstructured":"Caorsi, C., Pineda, F. & Munoz, C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw. \n                           19, 99\u2013103 (2008).","journal-title":"Eur Cytokine Netw."},{"key":"10600_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.joa.2016.01.010","volume":"32","author":"Y Carrascal","year":"2016","unstructured":"Carrascal, Y. et al. Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry). J Arrhythm. \n                           32, 191\u2013197 (2016).","journal-title":"J Arrhythm."},{"key":"10600_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/01.CCM.0000201407.89977.EA","volume":"34","author":"M Chello","year":"2006","unstructured":"Chello, M. et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med. \n                           34, 660\u2013667 (2006).","journal-title":"Crit Care Med."},{"key":"10600_CR25","doi-asserted-by":"crossref","unstructured":"Christenson, J. T. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 15, 394\u2013399, discussion 399\u2013400 (1999).","DOI":"10.1016\/S1010-7940(99)00034-2"},{"key":"10600_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/1074248414564869","volume":"20","author":"MR Dehghani","year":"2015","unstructured":"Dehghani, M. R., Kasianzadeh, M., Rezaei, Y. & Sepehrvand, N. Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized Trial. J Cardiovasc Pharmacol Ther. \n                           20, 465\u2013472 (2015).","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"10600_CR27","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1253\/circj.CJ-09-0352","volume":"73","author":"Q Ji","year":"2009","unstructured":"Ji, Q. et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J. \n                           73, 2244\u20132249 (2009).","journal-title":"Circ J."},{"key":"10600_CR28","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1253\/circj.69.636","volume":"69","author":"H Makuuchi","year":"2005","unstructured":"Makuuchi, H. et al. Effect of pravastatin on progression of coronary atherosclerosis in patients after coronary artery bypass surgery. Circ J. \n                           69, 636\u2013643 (2005).","journal-title":"Circ J."},{"key":"10600_CR29","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jtcvs.2008.06.038","volume":"136","author":"VA Mannacio","year":"2008","unstructured":"Mannacio, V. A., Iorio, D., De Amicis, V., Di Lello, F. & Musumeci, F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg. \n                           136, 1541\u20131548 (2008).","journal-title":"J Thorac Cardiovasc Surg."},{"key":"10600_CR30","volume":"30","author":"G Melina","year":"2009","unstructured":"Melina, G. et al. Preoperative HMG-CoA reductase inhibitors and atrial fibrillation in patients undergoing CABG: a prospective randomised trial. European Heart Journal. \n                           30, 32 (2009).","journal-title":"European Heart Journal."},{"key":"10600_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.106.621763","volume":"114","author":"G Patti","year":"2006","unstructured":"Patti, G. et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. \n                           114, 1455\u20131461 (2006).","journal-title":"Circulation."},{"key":"10600_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1536\/ihj.52.7","volume":"52","author":"Y Sun","year":"2011","unstructured":"Sun, Y. et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J. \n                           52, 7\u201311 (2011).","journal-title":"Int Heart J."},{"key":"10600_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0267659110385607","volume":"26","author":"PM Vukovic","year":"2011","unstructured":"Vukovic, P. M. et al. Steroids and statins: an old and a new anti-inflammatory strategy compared. Perfusion. \n                           26, 31\u201337 (2011).","journal-title":"Perfusion."},{"key":"10600_CR34","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","volume":"374","author":"Z Zheng","year":"2016","unstructured":"Zheng, Z. et al. Perioperative Rosuvastatin in Cardiac Surgery. N Engl J Med. \n                           374, 1744\u20131753 (2016).","journal-title":"N Engl J Med."},{"key":"10600_CR35","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.athoracsur.2015.09.070","volume":"101","author":"AF Barakat","year":"2016","unstructured":"Barakat, A. F. et al. Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting. Ann Thorac Surg. \n                           101, 818\u2013825 (2016).","journal-title":"Ann Thorac Surg."},{"key":"10600_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.clpt.2005.06.013","volume":"78","author":"E Lee","year":"2005","unstructured":"Lee, E. et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther. \n                           78, 330\u2013341 (2005).","journal-title":"Clin Pharmacol Ther."},{"key":"10600_CR37","volume":"20","author":"A Putzu","year":"2016","unstructured":"Putzu, A. et al. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials. Critical Care. 2016 \n                           20, 395 (2016).","journal-title":"Critical Care. 2016"},{"key":"10600_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/1074248415602557","volume":"21","author":"Y Rezaei","year":"2016","unstructured":"Rezaei, Y. et al. Statin Antiarrhythmic Effect on Atrial Fibrillation in Statin-Naive Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol Ther. \n                           21, 167\u2013176 (2016).","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"10600_CR39","doi-asserted-by":"crossref","unstructured":"Xiong, B. et al. Preoperative Statin Treatment for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomised Controlled Trials. Heart Lung Circ. (2017).","DOI":"10.1016\/j.hlc.2016.11.024"},{"key":"10600_CR40","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ijcard.2016.11.116","volume":"228","author":"X Yuan","year":"2017","unstructured":"Yuan, X., Du, J., Liu, Q. & Zhang, L. Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials. Int J Cardiol. \n                           228, 958\u2013966 (2017).","journal-title":"Int J Cardiol."},{"key":"10600_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. \n                           339, b2535 (2009).","journal-title":"BMJ."},{"key":"10600_CR42","doi-asserted-by":"crossref","unstructured":"Higgins J. P., Green S. Cochrane handbook for systematic reviews of interventions. Wiley Online Library. (2008).","DOI":"10.1002\/9780470712184"},{"key":"10600_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins, J. P. et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. \n                           343, d5928 (2011).","journal-title":"BMJ."},{"key":"10600_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo, S. P., Djulbegovic, B. & Hozo, I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. \n                           5, 13 (2005).","journal-title":"BMC Med Res Methodol."},{"key":"10600_CR45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ. \n                           327, 557\u2013560 (2003).","journal-title":"BMJ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10600-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10600-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10600-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:00:51Z","timestamp":1671789651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10600-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10600"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10600-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]},"assertion":[{"value":"5 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10091"}}